Introduction
Growth monitoring is a fundamental component of pediatric care, serving as an indicator of overall health and nutritional status. Accurate growth assessment requires selecting the appropriate growth chart for the child's age, feeding method, and any underlying conditions. The 2026 AAP Clinical Practice Guideline on Faltering Weight has introduced standardized z-score-based criteria and recommends replacing the term "failure to thrive" with "faltering weight."
WHO vs. CDC Growth Charts
WHO Growth Charts (2006)
The WHO growth charts are growth standards that describe how healthy children should grow under optimal environmental and health conditions. The reference population consisted of infants from six countries who were exclusively breastfed for at least 4 months and predominantly breastfed through 12 months.
CDC Growth Charts (2000)
The CDC growth charts are a growth reference that describes how children in the United States actually grew during a specific time period (1963-1994). The reference population included both breastfed and formula-fed infants.
Clinical Implications of Chart Selection
The practical difference is clinically significant:
- For the first 3 months of life, WHO charts show a somewhat faster rate of weight gain than CDC charts, leading to identification of more infants who appear to be growing slowly
- After approximately 3 months, formula-fed infants tend to gain weight more rapidly and may cross upward in percentiles on WHO charts, potentially being classified as overweight
- When WHO charts are used for U.S. children aged 6-23 months, fewer children will be identified as having inadequate weight for age
Using the wrong reference can lead to unnecessary investigation for nonexistent pathology or, conversely, missed identification of true growth concerns.
Current Recommendations
The CDC, NIH, and AAP recommend:
When using WHO growth charts to screen for abnormal growth, the 2.3rd and 97.7th percentiles (±2 standard deviations) are recommended as thresholds, rather than the 5th and 95th percentiles.
The Transition Problem
A 2025 study found that the abrupt switch from WHO to CDC charts at age 2 years causes clinically important changes in z-scores in children with stable growth patterns. The mean BMI-for-age z-score dropped by 0.59 at the transition, and 28.3% of children showed a drop in BMI z-score greater than 1.0. The authors developed "gradual transition" charts that use a weighted average from ages 2 to 5 years, which may reduce overidentification of slow weight gain.
Z-Scores vs. Percentiles
The 2026 AAP guideline recommends using z-scores rather than percentiles for growth assessment:
- Z-scores are the global standard for assessing and reporting nutritional status
- Z-scores do not have lower or upper limits, allowing precise description of measurements below the 1st percentile
- A change of 1 z-score reflects the same degree of change regardless of starting point (unlike percentiles)
- Z-scores enable comparison of populations and more precise tracking of treatment response
A z-score of 0 corresponds to the 50th percentile; a z-score of −2 corresponds to the 2.3rd percentile.
Faltering Weight: Updated Definition
The 2026 AAP/NASPGHAN Clinical Practice Guideline replaces "failure to thrive" with "faltering weight" and provides standardized diagnostic criteria:
Faltering weight is defined as any of the following:
- Weight-for-length or BMI-for-age less than −1.65 z-score (5th percentile)
- In children younger than 2 years, weight gain velocity less than −2 z-score for age (2.3rd percentile)
- Decline in weight, weight-for-length, or BMI ≥1 z-score
Not all children meeting these criteria have undernutrition. Children born large for gestational age commonly exhibit early declines in z-scores as they regress toward their genetic potential. This is physiologic, not pathologic. Similarly, children with genetic conditions may have different growth potentials.
The guideline recommends against routine diagnostic testing in the initial workup for faltering weight in children without specific signs, symptoms, or findings that would prompt focal evaluation.
Growth Velocity: The Critical Signal
Growth velocity, the rate of change over time, is often more informative than a single percentile measurement. Height deviating more than two major percentile lines represents abnormal growth compared with peers.
Normal Growth Velocity by Age
- Birth to 12 months: 23-27 cm/year
- 13-24 months: 10-14 cm/year
- 25-36 months: 8 cm/year
- 37-60 months: 7 cm/year
- 61 months to puberty: 5-6 cm/year
- Puberty (females): 8-12 cm/year
- Puberty (males): 10-14 cm/year
Growth velocity should be evaluated using measurements every 3 to 6 months in children older than 6 months; shorter intervals may be appropriate for younger children and specific clinical situations. Use the Growth Velocity calculator to track height velocity accurately.
Interpreting Velocity Patterns
A child growing consistently at 5 cm/year and tracking the 10th percentile likely represents normal genetic variation. By contrast, a child previously growing at 8 cm/year who decelerates to 3 cm/year represents a significant problem, even if the child remains at the 25th percentile. The deceleration in velocity is the critical red flag.
When weight velocity declines but height velocity is preserved, consider inadequate intake or malabsorption. When height velocity declines, consider systemic illness or endocrine disorders.
Preterm Infants: Age Correction
Preterm infants require age correction for accurate growth assessment. Corrected age accounts for the time the infant would have remained in utero:
Corrected age = Chronologic age − (40 weeks − Gestational age at birth)
Duration of Age Correction
A 2025 study of extremely and very preterm infants found that using chronological age resulted in misclassification of up to 72.9% as stunted and 89.8% as underweight at term-equivalent age. The study concluded that age correction is required for all growth measures through 36 months of corrected age for extremely (<28 weeks) and very preterm (28 to <32 weeks) infants.
Growth Chart Selection for Preterm Infants
The AAP recommends:
- Fenton Preterm Growth Chart (updated 2025): Use until 50 weeks postmenstrual age
- WHO growth charts with corrected age: Use from 50 weeks postmenstrual age until 24 months corrected age
- After 24 months corrected age: Transition to standard charts
The INTERGROWTH-21st Preterm Postnatal Growth Standards provide an alternative approach, with curves that overlap with WHO Child Growth Standards by 64 weeks postmenstrual age (6 months corrected age) without requiring adjustment.
Syndrome-Specific Growth Charts
Children with genetic syndromes have inherent differences in growth potential. Plotting them on standard charts may incorrectly suggest pathology. Condition-specific growth charts are available for:
Down syndrome: The Down Syndrome Growing Up Study (DSGS) charts (2015) are based on 1,520 measurements from 637 U.S. participants and show marked improvements compared with older charts. A 2026 Italian study developed Mediterranean-specific charts, finding statistically significant differences from U.S. charts in weight and BMI distribution. Use the Down Syndrome Growth calculator.
Turner syndrome: Syndrome-specific charts account for the characteristic short stature and growth pattern. Use the Turner Syndrome Growth calculator.
Achondroplasia: The AAP 2020 health supervision guidelines include syndrome-specific charts for height, weight, and head circumference. Additional charts for body proportions (sitting height, arm span, leg length) are available.
Prader-Willi syndrome, Noonan syndrome, cri du chat syndrome: Condition-specific charts are available, though based on smaller data samples.
Using both syndrome-specific and standard charts in parallel can help identify unexpected growth problems superimposed on the underlying condition.
Percentile Crossing in Infancy
In the first 6-12 months of life, normal infants frequently cross percentiles as they regress toward their genetic growth potential. An infant born large due to maternal diabetes may track the 95th percentile at birth but settle to the 50th percentile by 6 months. This is physiologic.
Children born with anthropometric z-scores greater than 0 (>50th percentile) are much more likely to exhibit declines in z-scores during the first 2 years of life.
Findings that warrant concern include:
- Persistent downward crossing of percentiles
- Large percentile drops (e.g., falling from 75th to 10th percentile in 3 months)
- Declining height velocity
- Weight-for-length or BMI z-score less than −1.65
- Decline in z-score ≥1.0
Midparental Height
Sex-adjusted midparental height calculations should be performed to evaluate growth velocity and compare predicted adult height with genetic potential:
- Boys: (Mother's height + Father's height + 13 cm) / 2
- Girls: (Mother's height + Father's height − 13 cm) / 2
A child's predicted adult height (estimated by projecting the current growth curve percentile into adulthood) should be compared with midparental height to help distinguish normal variants from pathologic stature.
Bone Age Assessment
Bone age compared with chronologic age helps narrow the differential diagnosis in children with short or tall stature:
- Bone age delayed >2 SD: Suggests constitutional delay of growth and puberty, hypothyroidism, growth hormone deficiency, or chronic illness
- Bone age advanced >2 SD: Suggests precocious puberty, hyperthyroidism, or obesity
- Bone age = chronologic age with short stature: Suggests familial short stature or genetic syndrome
Practical Recommendations
- Select the appropriate growth chart: WHO for children <2 years, CDC for children ≥2 years, Fenton for preterm infants, syndrome-specific charts for genetic conditions.
- Use z-scores for precise assessment, particularly for children at extremes of the growth curve or when tracking treatment response.
- Correct for prematurity through at least 24 months corrected age; for extremely preterm infants, correction through 36 months may be appropriate.
- Track growth velocity with measurements every 3-6 months in children older than 6 months.
- Calculate midparental height to establish genetic growth potential and compare with predicted adult height.
- Recognize physiologic percentile crossing in the first 6-12 months of life, particularly in infants born large for gestational age.
- Use consistent charts throughout follow-up. Switching references mid-follow-up creates the appearance of sudden percentile changes in a child with stable growth.
- Avoid routine diagnostic testing in children with faltering weight who lack specific signs or symptoms suggesting underlying disease.
- Consider bone age when evaluating short or tall stature to help differentiate constitutional delay from pathologic conditions.
- Interpret growth in clinical context. A single measurement is less informative than the trajectory over time. Growth velocity is often more revealing than absolute percentile position.
References
- Kersten HB, Goday PS, Abdelhadi R, et al. Clinical Practice Guideline for Diagnosis and Management of Faltering Weight. Pediatrics. 2026;e2025075764.
- Grummer-Strawn LM, Reinold C, Krebs NF. Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. CDC (2010).
- Grummer-Strawn LM, Reinold C, Krebs NF. Use of World Health Organization and CDC Growth Charts for Children Aged 0-59 Months in the United States. MMWR Recomm Rep. 2010;59(RR-9):1-15.
- Caro R, Savel P, Moss PI. Evaluation of Short and Tall Stature in Children. Am Fam Physician. 2025;111(6):532-542.
- Daymont C, Hwang W, Paul IM, Shur N, Freedman DS. Creation and Evaluation of New Growth Charts With a Gradual Transition From WHO to CDC Values. Pediatrics. 2025;e2025070697.
- Allen DB, Cuttler L. Short Stature in Childhood — Challenges and Choices. N Engl J Med. 2013;368(13):1220-1228.
- Elmrayed S, Dai S, Lodha A, Kumar M, Fenton TR. Preterm Growth Assessment: The Latest Findings on Age Correction. J Perinatol. 2025;45(5):607-615.
- Bybel M, Delaney CA, Coble K. Outpatient Care of the Premature Infant. Am Fam Physician. 2025;112(2):153-161.
- Villar J, Giuliani F, Barros F, et al. Monitoring the Postnatal Growth of Preterm Infants: A Paradigm Change. Pediatrics. 2018;141(2):e20172467.
- Villar J, Giuliani F, Bhutta ZA, et al. Postnatal Growth Standards for Preterm Infants: The Preterm Postnatal Follow-Up Study of the INTERGROWTH-21st Project. Lancet Glob Health. 2015;3(11):e681-691.
- Zemel BS, Pipan M, Stallings VA, et al. Growth Charts for Children With Down Syndrome in the United States. Pediatrics. 2015;136(5):e1204-1211.
- Cattoni A, Molinari S, Cali L, et al. TRISOMY 21: Development of Syndrome-Specific Growth Charts From a Wide Italian Cohort and Validation of BMI as a Predictor of Increased Risk of Metabolic Derangement. J Endocrinol Invest. 2026;49(4):931-946.
- Hoover-Fong J, Scott CI, Jones MC. Health Supervision for People With Achondroplasia. Pediatrics. 2020;145(6):e20201010.
- Neumeyer L, Merker A, Hagenas L. Clinical Charts for Surveillance of Growth and Body Proportion Development in Achondroplasia and Examples of Their Use. Am J Med Genet A. 2021;185(2):401-412.
- Goodwin ET, Buel KL, Cantrell LD. Growth Faltering and Failure to Thrive in Children. Am Fam Physician. 2023;107(6):597-603.
- Hetman M, Moreira H, Barg E. The Best Tool for the Assessment of Developmental Disorders in Children With Down Syndrome: Comparison of Standard and Specialized Growth Charts. Front Endocrinol. 2022;13:928151.